Study to Evaluate the Safety and Efficacy of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain
Status: | Completed |
---|---|
Conditions: | Arthritis, Osteoarthritis (OA) |
Therapuetic Areas: | Rheumatology |
Healthy: | No |
Age Range: | 45 - 80 |
Updated: | 3/15/2017 |
Start Date: | August 2015 |
End Date: | February 2017 |
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging 24-Week Study to Evaluate the Safety and Efficacy of a Single Injection of CNTX-4975 in Subjects With Chronic, Moderate to Severe Osteoarthritis Knee Pain
The purpose of this study is to evaluate the safety and efficacy of a single injection of
CNTX-4975 in subjects with chronic, moderate to severe osteoarthritis knee pain.
CNTX-4975 in subjects with chronic, moderate to severe osteoarthritis knee pain.
Inclusion Criteria:
- Radiography of both knees with a posterior-anterior, fixed flexion view taken during
the Screening period. The index knee must show evidence of chronic OA.
- Moderate to severe pain in the index knee associated with OA must be stable for a
minimum of 2 months prior to Screening, as assessed by the Investigator.
- A specified mean pain score in the index knee over the 7 days prior to dosing, based
on question A1 of the Western Ontario and McMaster Universities Osteoarthritis Index
(WOMAC A1).
- Specified baseline and screening scores on the WOMAC A1
- Body Mass Index ≤ 45 kg/m2.
- Subjects must have had a therapeutic failure (no relief, or inadequate relief),
and/or AEs resulting in stopping treatment, and/or contraindication to the standard
of care appropriate to the severity of the index knee OA pain they are experiencing.
Exclusion Criteria:
- Joint replacement surgery of the index knee at any time, or open surgery of the index
knee in the past 12 months.
- Prior arthroscopic surgery of the index knee within 3 months of Screening.
- Any painful conditions of the index knee due to joint disease other than OA.
- Mild pain in the non-index knee when walking.
- Other chronic pain anywhere in the body that requires the use of analgesic
medications.
- Secondary OA of the index knee due to acute traumatic injury.
- Significant current or past instability (e.g., cruciate ligament tear or rupture or
previous repair) or misalignment (> 10 degrees varus or valgus) of the index knee
- Has used topical capsaicin on the index knee within 90 days of Screening.
- Corticosteroid injection in the index knee within 90 days of Screening.
- Received IA viscosupplementation (e.g., Synvisc®, Hyalgan®) within 90 days of
Screening.
- Prior participation in an ALGRX 4975 or CNTX-4975 study.
- Has any of the following characteristics:
1. active or historic substance use disorder within the previous year as defined by
the Diagnostic and Statistical Manual for Mental Health Disorders, fifth
edition, or
2. tests positive upon urine drug screen for a substance of abuse.
- Has moderate to severe depression or anxiety.
We found this trial at
22
sites
Canoga Park, California 91303
Principal Investigator: Hessam Aazami
Phone: 818-999-4673
Click here to add this to my saved trials
Site Overview Achieve has two clinical research sites in Birmingham, AL. Our Birmingham sites are conveniently located...
Click here to add this to my saved trials
860 Peachwood Drive
DeLand, Florida 32720
DeLand, Florida 32720
(386) 740-0770
Principal Investigator: Melanie VanDemark
Phone: 386-785-2400
Site Overview Avail Clinical Research is a renowned and experienced clinical research site conducting Phase...
Click here to add this to my saved trials
100 West Gore St # 202
Orlando, Florida 32806
Orlando, Florida 32806
(407) 426-9299
Principal Investigator: Kevin Radbill
Phone: 407-426-9299
Compass Research LLC Compass Research is a clinical research company dedicated to testing new medications...
Click here to add this to my saved trials
Altoona, Pennsylvania 16602
Principal Investigator: Christopher McClellan
Phone: 814-949-4050
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Hartsdale, New York 10530
Principal Investigator: Statish Modugu
Phone: 914-341-2346
Click here to add this to my saved trials
Hialeah, Florida 33012
Principal Investigator: Maria Fernandez
Phone: 786-343-3902
Click here to add this to my saved trials
Click here to add this to my saved trials
Kansas City, Missouri 64114
Principal Investigator: John Ervin
Phone: 816-943-0770
Click here to add this to my saved trials
La Mesa, California 91942
Principal Investigator: Peter Hanson
Phone: 619-315-0314
Click here to add this to my saved trials
Click here to add this to my saved trials
Los Angeles, California 90036
Principal Investigator: Lydia Hazan
Phone: 310-289-8242
Click here to add this to my saved trials
286 Westward Drive
Miami, Florida 33185
Miami, Florida 33185
Principal Investigator: Ignacio Rodriguez
Phone: 305-480-0100
Click here to add this to my saved trials
Click here to add this to my saved trials
3100 Duraleigh Rd
Raleigh, North Carolina 27612
Raleigh, North Carolina 27612
(919) 781-2514
Principal Investigator: Wayne Harper
Phone: 919-781-2514
Wake Research Associates, LLC Wake Research is an Organization of Unified Investigational Sites working closely...
Click here to add this to my saved trials
Click here to add this to my saved trials
Stockbridge, Georgia 30281
Principal Investigator: Nathan Segall
Phone: 770-507-6867
Click here to add this to my saved trials
Click here to add this to my saved trials
Tuscon, Arizona 85712
Principal Investigator: Dena Petersen
Phone: 520-612-7860
Click here to add this to my saved trials